Management of labor and delivery in myasthenia gravis: A new protocol.


Journal

The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761

Informations de publication

Date de publication:
May 2019
Historique:
received: 21 09 2018
accepted: 26 12 2018
pubmed: 26 2 2019
medline: 3 9 2019
entrez: 27 2 2019
Statut: ppublish

Résumé

Pregnancy with myasthenia gravis (MG) is known to be associated with an increased cesarean section rate, presumably due to maternal fatigue during labor. Although epidural labor analgesia (ELA) appears to be a good option for circumventing maternal fatigue, a protocol for managing MG deliveries has not been established. This study, based on a review of our case series, aimed to evaluate the validity of our management protocol for maternal MG, in which ELA is used depending on MG severity. Parturients with systemic muscle weakness or worsening symptoms were classified as Category A (A), and those without symptoms were classified as Category B (B). In A, ELA was given at the onset of labor. Immediate vacuum delivery was done once the fetal head descended to station +2. For B, spontaneous vaginal delivery was chosen. The duration, blood loss, fetal weight, Apgar score and MG symptoms on post-partum day (PPD) 1, 14 and 30 were recorded. Six patients were enrolled. Four were classified in A, and two were classified in B. No adverse events occurred during labor. Transvaginal delivery was successfully achieved in all the patients. Symptoms of MG were well-controlled. MG symptoms were stable on PPD 1 in all the patients although two patients complained of worsening symptoms after PPD 14. Women with MG can safely undergo spontaneous or operative vaginal delivery. ELA is a good option for circumventing the effects of maternal fatigue on delivery. Our protocol may lower the cesarean section rate in maternal MG.

Identifiants

pubmed: 30806001
doi: 10.1111/jog.13922
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

974-980

Informations de copyright

© 2019 Japan Society of Obstetrics and Gynecology.

Auteurs

Kotoi Tsurane (K)

Obstetrics and Gynecology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Perinatal and Women's Medicine, Tokyo Medical and Dental University Hospital, Tokyo, Japan.

Serabi Tanabe (S)

Anesthesiology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.

Naoyuki Miyasaka (N)

Perinatal and Women's Medicine, Tokyo Medical and Dental University Hospital, Tokyo, Japan.

Minako Matsuda (M)

Obstetrics and Gynecology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.

Megumi Takahara (M)

Obstetrics and Gynecology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.

Tsutomu Ida (T)

Obstetrics and Gynecology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.

Akira Kohyama (A)

Obstetrics and Gynecology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH